A study on P2x purinoceptors mediating the electrophysiological and contractile effects of purine nucleotides in rat vas deferens
Open Access
- 1 May 1995
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 115 (1) , 177-185
- https://doi.org/10.1111/j.1476-5381.1995.tb16336.x
Abstract
1 We have studied both the electrophysiological and contractile effects of the purine nucleotide, adenosine-5′-triphosphate (ATP), as well as a number of its structural analogues as agonists at P2X purinoceptors in the rat vas deferens in vitro. 2 Electrophysiological effects were investigated by a whole cell voltage clamp technique (holding potential − 70 mV) with fast flow concentration-clamp applications of agonists in single isolated smooth muscle cells. ATP, 2-methylthio adenosine-5′-triphosphate (2-MeSATP) and α, β methylene adenosine-5′-triphosphate (αβ-meATP) all evoked inward currents over a similar concentration range (0.3–10 μM), being approximately equipotent with similar concentrations for threshold effects (0.3 μM). ADP (10 μM) also evoked a rapid current of similar peak amplitude to that seen with ATP (10 μM). 3 α,β-meATP was the most potent agonist in producing contractions of the rat vas deferens whole tissue preparation, with a threshold concentration equal to that in the electrophysiological studies (0.3 UM). However, ATP and 2-MeSATP were at least ten times less potent in studies measuring contraction than in the electrophysiological studies. Furthermore, their concentration-effect curves were shallow with smaller maximal responses than could be achieved with α,β-meATP. ADP, AMP and adenosine were inactive at concentrations up to 1 mM. The rank order of agonist potencies observed for contraction was α,β-meATP≫ATP = 2-MeSATP. 4 Measurement of inorganic phosphate (iP), as a marker of purine nucleotide metabolism in the vas deferens whole tissue preparation, indicated that ATP and 2-MeSATP were rapidly metabolized, whereas α,β-meATP was stable for up to 2 h. Removal of divalent cations prevented breakdown of ATP and 2-MeSATP, suggesting that metabolism involved a Ca2+/Mg2+-dependent enzyme. 5 It appears that in isolated preparations of rat vas deferens, the low potency of ATP and 2-MeSATP can be explained by rapid agonist breakdown by ectonucleotidases. However, this is not the case in the single cell studies where the use of rapid concentration-clamp applications revealed the true potency of the agonists. Under such conditions the three agonists were all equal in potency indicating that the rank order of agonist potencies of α,β-meATP≫ATP = 2-MeSATP is not in fact characteristic of smooth muscle P2X-purinoceptors as commonly believed.Keywords
This publication has 43 references indexed in Scilit:
- Is there a basis for distinguishing two types of P2-purinoceptor?Published by Elsevier ,2002
- G protein-coupled receptors for ATP and other nucleotides: a new receptor familyTrends in Pharmacological Sciences, 1994
- Purinoceptors: Are there families of P2X and P2Y purinoceptors?Pharmacology & Therapeutics, 1994
- Cloning and functional expression of a brain G‐protein‐coupled ATP receptorFEBS Letters, 1993
- Purinoceptor nomenclature: A status reportDrug Development Research, 1993
- Regional variation in purinergic and adrenergic responses in isolated vas deferens of rat, rabbit and guinea‐pigJournal of Autonomic Pharmacology, 1992
- Noradrenaline-ATP co-transmission in the sympathetic nervous systemTrends in Pharmacological Sciences, 1991
- Overview: Purinergic MechanismsAnnals of the New York Academy of Sciences, 1990
- The changing face of autonomic neurotransmission*Acta Physiologica Scandinavica, 1986
- Evidence to support the hypothesis that ATP is a co-transmitter in rat vas deferensCellular and Molecular Life Sciences, 1983